Research Methodologies Followed for This Study:

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the transdermal drug delivery systems market. The primary sources from the demand side include personnel from research organizations, academic institutes, and purchase managers.

# A robust primary research methodology has been adopted to validate the contents of the report

# Both telephonic and e-mail interviews of primary participants were conducted through questionnaires

Secondary Research:

In the secondary research process, various secondary sources such as the International Association for the Study of Pain (IASP), International Parkinson and Movement Disorder Society, World Parkinson Congress, International Planned Parenthood Federation (IPPF), International Society of Endocrinology, International Diabetes Federation, International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), European Pain Federation (EFIC), European Society of Contraception and Reproductive Health (ESC), European Society of Cardiology, European Parkinson's Disease Association (EPDA), European Association for the Study of Diabetes (EASD), Asia Pacific Council on Contraception (APCOC), Asian Pacific Society of Cardiology, ASEAN Federation of Endocrine Societies, Guttmacher Institute, National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), United Nations Department of Economic and Social Affairs, directories, industry journals, databases, press releases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203190114

Expected Revenue Growth:

The Transdermal Drug Delivery Research Market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems.

Market Size Estimation:

Top-down and bottom-up approaches were used to validate the size of the transdermal drug delivery system market and estimate the size of other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Home care settings segment is expected to grow at the fastest rate during the forecast period

On the basis of end users, the transdermal drug delivery system market is segmented into home care settings and hospitals & clinics. The home care settings segment is expected to grow at a higher CAGR during the forecast period. The high growth in this segment can be attributed to the increase in self-administration of medication at home, rapid growth in the geriatric population across the globe, and the growing need for cost-effective drug administration.

North America is expected to hold the largest market share during the forecast period

North America is one of the major revenue generating regions in the transdermal drug delivery system market. The Transdermal Drug Delivery Research Market in the region is driven by the rising prevalence of targeted diseases (such as chronic pain, central nervous system disorders, and cardiovascular diseases) in the region, the increasing use of contraceptives, and the increasing number of research activities related to transdermal drug delivery systems.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=203190114

Key Market Players:

The key players in the Transdermal Drug Delivery Research Market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), and GlaxoSmithKline (UK). Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

[email protected]